Related Experiment Video
Updated: Feb 13, 2026

Author Spotlight: Understanding the Propagation of Closed Circular Extrachromosomal rDNA Containing Element (CERE) in Naegleria gruberi
Published on: June 21, 2024
The therapeutic strategies against Naegleria fowleri
Natália Karla Bellini1, Thomás Michelena Santos1, Marco Túlio Alves da Silva1
1Instituto de Física de São Carlos, Universidade de São Paulo, Caixa Postal 369, 13560-590, São Carlos, SP, Brazil.
Abstract:
Naegleria fowleri is a pathogenic amoeboflagellate most prominently known for its role as the etiological agent of the Primary Amoebic Meningoencephalitis (PAM), a disease that afflicts the central nervous system and is fatal in more than 95% of the reported cases. Although being fatal and with potential risks for an increase in the occurrence of the pathogen in populated areas, the organism receives little public health attention. A great underestimation in the number of PAM cases reported is assumed, taking into account the difficulty in obtaining an accurate diagnosis. In this review, we summarize different techniques and methods used in the identification of the protozoan in clinical and environmental samples. Since it remains unclear whether the protozoan infection can be successfully treated with the currently available drugs, we proceed to discuss the current PAM therapeutic strategies and its effectiveness. Finally, novel compounds for potential treatments are discussed as well as research on vaccine development against PAM.
Insights
Naegleria fowleri causes Primary Amoebic Meningoencephalitis (PAM), a fatal brain infection. This review covers diagnosis, current treatments, and potential new therapies and vaccines for PAM.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Neuroscience
Background:
- Naegleria fowleri is a pathogenic amoeboflagellate responsible for Primary Amoebic Meningoencephalitis (PAM).
- PAM is a devastating central nervous system infection with a fatality rate exceeding 95%.
- Despite its severity, Naegleria fowleri and PAM receive insufficient public health attention, potentially due to underdiagnosis.
Purpose of the Study:
- To review current diagnostic techniques for Naegleria fowleri in clinical and environmental samples.
- To evaluate the effectiveness of existing therapeutic strategies for PAM.
- To explore novel therapeutic compounds and vaccine development for PAM.
Main Methods:
- Literature review of diagnostic methods for Naegleria fowleri.
- Analysis of current treatment protocols and their clinical outcomes for PAM.
- Survey of emerging research on potential drug candidates and vaccine strategies.
Main Results:
- Various methods exist for identifying Naegleria fowleri, but accurate diagnosis remains challenging.
- The effectiveness of current PAM treatments is limited, and successful treatment outcomes are rare.
- Promising novel compounds and vaccine research are underway for PAM.
Conclusions:
- Improved diagnostic accuracy is crucial for timely PAM intervention.
- Current therapeutic options for PAM are inadequate, necessitating further research.
- Development of new treatments and vaccines is essential to combat Naegleria fowleri infections.
Related Concept Videos
Therapeutic Index
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Persuasion Strategies
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Microorganisms in Medicine and Therapeutics
Coping Strategies: Problem Focused
For example, consider a student who struggles to understand their...

